SCHEMBL20182245

SCHEMBL20182245

CCC(c1cn(-c2ccccc2F)nn1)n1cc(BOC(C)(C)C(C)(C)O)c2c(Cl)ncnc21

nearest known ligand 0.44

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CFTR P13569 10/20 0.44
NOTUM Q6P988 1/20 0.32
GRM1 Q13255 2/20 0.31
GRM5 P41594 1/20 0.31
RXRA P19793 2/20 0.31
GRIN1 Q05586 2/20 0.31
GRIN2B Q13224 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20182238 0.90 CFTR (0.36) CFTRNOTUMGRM1GRM5RXRA
SCHEMBL20162879 0.81 CFTR (0.49) CFTRNOTUM
SCHEMBL20162875 0.76 CFTR (0.45) CFTRNOTUMRXRAGRIN1GRIN2B
SCHEMBL30037449 0.76 CFTR (0.45) CFTRNOTUMRXRAGRIN1GRIN2B
SCHEMBL20162877 0.75 CFTR (0.46) CFTRNOTUM
SCHEMBL30892146 0.75 CFTR (0.46) CFTRNOTUM
SCHEMBL20162728 0.72 CFTR (0.59) CFTRNOTUM
SCHEMBL30036823 0.72 CFTR (0.59) CFTRNOTUM
SCHEMBL30037958 0.72 CFTR (0.56) CFTR
SCHEMBL20162615 0.72 CFTR (0.56) CFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018094137-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) 2018-05-24 WO disclosed